| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/TOXSCI/54.1.19 |
| P698 | PubMed publication ID | 10746928 |
| P2093 | author name string | M E McManus | |
| D M Grant | |||
| A Gaedigk | |||
| P M Hall | |||
| H Samaratunga | |||
| K F Windmill | |||
| P433 | issue | 1 | |
| P304 | page(s) | 19-29 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | Toxicological Sciences | Q2446966 |
| P1476 | title | Localization of N-acetyltransferases NAT1 and NAT2 in human tissues | |
| P478 | volume | 54 |
| Q26829025 | Arylamine N-acetyltransferase 1: a novel drug target in cancer development |
| Q37225883 | Association Between NAT2 Polymorphisms and Lung Cancer Susceptibility |
| Q38739489 | Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts |
| Q38926656 | Biomarkers in Occupational Asthma. |
| Q27000798 | Dietary interactions with the bacterial sensing machinery in the intestine: the plant polyphenol case |
| Q28477297 | Effects of single nucleotide polymorphisms on human N-acetyltransferase 2 structure and dynamics by molecular dynamics simulation |
| Q88165727 | Elucidation of the Intestinal Absorption of para-Aminobenzoic Acid, a Marker for Dietary Intake |
| Q61811752 | Exposure of Infants to Isoniazid via Breast Milk After Maternal Drug Intake of Recommended Doses Is Clinically Insignificant Irrespective of Metaboliser Status. A Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach to Estimate Drug Exposu |
| Q40336825 | Expression of folate pathway genes in the cartilage of Hoxd4 and Hoxc8 transgenic mice |
| Q42911521 | Frequent loss of heterozygosity at 8p22 chromosomal region in diffuse type of gastric cancer |
| Q28506641 | Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene |
| Q92170011 | Genomewide Association Study Confirming the Association of NAT2 with Susceptibility to Antituberculosis Drug-Induced Liver Injury in Thai Patients |
| Q40503646 | Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5'-UTR splice variants with altered translational activities |
| Q24812168 | Hazardous air pollutants and asthma |
| Q37046402 | Helicobacter pylori infection and antioxidants can modulate the genotoxic effects of heterocyclic amines in gastric mucosa cells |
| Q48232407 | High N-acetyltransferase 1 (NAT1) expression is associated with estrogen receptor expression in breast tumors, but is not under direct regulation by estradiol, 17beta-diol, or dihydrotestosterone in breast cancer cells |
| Q45268014 | Host factors in occupational diisocyanate asthma: a Swiss longitudinal study |
| Q35911107 | Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues. |
| Q40639399 | Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1). |
| Q34225242 | Inflammatory cytokines suppress arylamine N-acetyltransferase 1 in cholangiocarcinoma cells |
| Q58234962 | Influence of polymorphic metabolic enzymes on biotransformation and effects of diphenylmethane diisocyanate |
| Q28076859 | Isoniazid metabolism and hepatotoxicity |
| Q85191937 | Measuring the Activity of Arylamine N‐Acetyltransferase (NAT) |
| Q46428539 | Mesalazine pharmacokinetics and NAT2 phenotype |
| Q41829325 | Metabolic enzyme considerations in cancer therapy |
| Q36447072 | Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study |
| Q28728127 | N-Acetyltransferase 1 (NAT1) Genotype: A Risk Factor for Urinary Bladder Cancer in a Lebanese Population |
| Q87370046 | N-Acetyltransferase 2 (NAT2) gene polymorphism and exposure to smoking in lung cancer of Chinese males |
| Q34591190 | N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer |
| Q50222855 | N-acetyl transferase 2/environmental factors and their association as a modulating risk factor for sporadic colon and rectal cancer. |
| Q73109979 | N-acetyl transferase-2 and bladder cancer risk: a meta-analysis |
| Q40305233 | N-acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout mice |
| Q28388128 | N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk |
| Q23910398 | N-acetyltransferase 2 genotypes are associated with diisocyanate-induced asthma |
| Q42090708 | PharmGKB summary: isoniazid pathway, pharmacokinetics. |
| Q39133736 | Polymorphisms in NAT2 Gene and Atherosclerosis in an Algerian Population |
| Q36477402 | Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer |
| Q26771643 | Risks on N-acetyltransferase 2 and bladder cancer: a meta-analysis |
| Q54772782 | Skeletal Muscles Express the Xenobiotic-metabolizing Enzyme ArylamineN-acetyltransferase |
| Q87851717 | Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population |
| Q40669427 | Xenobiotic inducible regions of the human arylamine N-acetyltransferase 1 and 2 genes |
| Q35990861 | mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs |
Search more.